Angiex Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Angiex, developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, has appointed Marty J. Duvall as chief.

Martyj duvallPaul jaminetAngiex founderPresident paul jaminetOrbimed advisorsAngiex inc